Maintaining control over illness: a model of partner activity in prostate cancer.
about
The Experience of Caregivers Living with Cancer Patients: A Systematic Review and Meta-SynthesisImpact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.The experience and perceptions of men with prostate cancer and their partners of the CONNECT psychosocial intervention: a qualitative exploration.Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy.Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer.Coping in men with prostate cancer and their partners: a quantitative and qualitative study.The language of prostate cancer treatments and implications for informed decision making by patients.
P2860
Q26776520-4B28F636-6596-4D87-B187-723FE0A50AC8Q37373089-420A8128-DF7D-414A-91E7-223F048F344AQ41147152-907FF1E0-BF1C-47D8-9B32-A76C032EE25CQ47575426-12A3B33B-B078-4A11-A615-2E1E36D6B63DQ48658811-C8990ADB-FA9A-4B4C-860A-914BBA953FAFQ48797953-B9892494-8238-45F3-8D3E-5A3F6E605679Q51340619-F56639D4-DE63-4B8F-AFEF-BB75C854293A
P2860
Maintaining control over illness: a model of partner activity in prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Maintaining control over illness: a model of partner activity in prostate cancer.
@en
Maintaining control over illness: a model of partner activity in prostate cancer.
@nl
type
label
Maintaining control over illness: a model of partner activity in prostate cancer.
@en
Maintaining control over illness: a model of partner activity in prostate cancer.
@nl
prefLabel
Maintaining control over illness: a model of partner activity in prostate cancer.
@en
Maintaining control over illness: a model of partner activity in prostate cancer.
@nl
P1476
Maintaining control over illness: a model of partner activity in prostate cancer.
@en
P2093
P304
P356
10.1111/J.1365-2354.2008.01047.X
P407
P50
P577
2009-10-15T00:00:00Z